Matthew Caufield's Stock Ratings

HC Wainwright & Co. Analyst

Matthew Caufield is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/31/2024

Overall Average Return

-31.8%

Smart Score

35.6%

Overall Average Return Percentile

6th

Number of Ratings

109
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

What 5 Analyst Ratings Have To Say About 4D Molecular Therapeutics
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Analyst Expectations For 4D Molecular Therapeutics's Future
This NANO Nuclear Energy Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Wednesday
This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
The Latest Analyst Ratings For 4D Molecular Therapeutics
Peeling Back The Layers: Exploring 4D Molecular Therapeutics Through Analyst Insights
Assessing 4D Molecular Therapeutics: Insights From 7 Financial Analysts
Lyra Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Analyst Expectations For 4D Molecular Therapeutics's Future
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved